2014
DOI: 10.1071/ch13321
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Characterisation, Interaction with DNA, Cytotoxicity, and Apoptotic Studies of Ruthenium(II) Polypyridyl Complexes

Abstract: We report the synthesis and characterisation of two new ruthenium(II) polypyridyl complexes containing monodentate ancillary ligands [Ru(L) 4 (4HEPIP)], where L ¼ 4-aminopyridine (1) or pyridine (2) and 4HEPIP ¼ 2-(4-hydroxy-3-ethoxyphenyl)-1H-imidazo[4,5-f][1,10](phenanthroline). These complexes were characterised by elemental analysis and ultraviolet-visible, infrared, and 1 H NMR spectroscopy. The binding properties of the two complexes towards calf thymus (CT)-DNA were investigated with different spectroph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…28 DNA having all the genetic information/coding for cellular functions, such as cell replication and transcription, is usually a primary target for most of the anticancer drugs. [29][30][31][32][33][34][35][36][37][38][39] Anticancer drug molecules interact with DNA through different noncovalent interactions, depending on the structure of the drug, and can modify/unwind the double stranded helical structure of DNA and destroy its normal functions, ultimately leading to cell death. The interaction of anticancer drug molecules with DNA can be categorized into three types: (i) electrostatic interaction with the anionic phosphate of DNA backbone, (ii) intercalation into the stacked base pairs of DNA and (iii) groove binding.…”
Section: Introductionmentioning
confidence: 99%
“…28 DNA having all the genetic information/coding for cellular functions, such as cell replication and transcription, is usually a primary target for most of the anticancer drugs. [29][30][31][32][33][34][35][36][37][38][39] Anticancer drug molecules interact with DNA through different noncovalent interactions, depending on the structure of the drug, and can modify/unwind the double stranded helical structure of DNA and destroy its normal functions, ultimately leading to cell death. The interaction of anticancer drug molecules with DNA can be categorized into three types: (i) electrostatic interaction with the anionic phosphate of DNA backbone, (ii) intercalation into the stacked base pairs of DNA and (iii) groove binding.…”
Section: Introductionmentioning
confidence: 99%